Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
47.31
Dollar change
-0.02
Percentage change
-0.04
%
IndexRUT P/E- EPS (ttm)-6.81 Insider Own14.41% Shs Outstand68.19M Perf Week-3.67%
Market Cap3.23B Forward P/E- EPS next Y-5.51 Insider Trans11.16% Shs Float58.51M Perf Month3.75%
Income-464.52M PEG- EPS next Q-1.41 Inst Own106.02% Short Float11.43% Perf Quarter60.21%
Sales0.00M P/S- EPS this Y59.05% Inst Trans- Short Ratio6.29 Perf Half Y139.30%
Book/sh4.24 P/B11.15 EPS next Y-5.47% ROA-179.22% Short Interest6.69M Perf Year211.45%
Cash/sh3.69 P/C12.81 EPS next 5Y- ROE-238.08% 52W Range12.35 - 50.68 Perf YTD10.54%
Dividend Est.- P/FCF- EPS past 5Y- ROI-145.94% 52W High-6.65% Beta4.18
Dividend TTM- Quick Ratio4.99 Sales past 5Y0.00% Gross Margin- 52W Low283.08% ATR (14)2.38
Dividend Ex-Date- Current Ratio4.99 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)54.64 Volatility5.11% 4.75%
Employees202 Debt/Eq0.11 Sales Y/Y TTM- Profit Margin- Recom1.09 Target Price53.10
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q-48.62% Payout- Rel Volume0.65 Prev Close47.33
Sales Surprise- EPS Surprise-13.11% Sales Q/Q- EarningsNov 14 AMC Avg Volume1.06M Price47.31
SMA201.39% SMA507.59% SMA20067.13% Trades Volume686,800 Change-0.04%
Date Action Analyst Rating Change Price Target Change
Feb-16-24Initiated RBC Capital Mkts Outperform $62
Feb-06-24Initiated UBS Buy $59
Dec-22-23Initiated H.C. Wainwright Buy $50
Dec-08-23Initiated Robert W. Baird Outperform $58
Jan-24-23Initiated SVB Securities Outperform $24
Jan-04-23Initiated JP Morgan Overweight $23
Dec-02-22Initiated BTIG Research Buy $24
Oct-26-22Upgrade Cantor Fitzgerald Neutral → Overweight $158 → $27
Oct-12-22Initiated Piper Sandler Overweight $23
Aug-19-22Downgrade Piper Sandler Overweight → Neutral $149
Jan-25-24 05:31PM
Jan-22-24 07:00AM
Jan-08-24 07:30AM
Jan-02-24 07:00AM
Dec-31-23 03:01AM
04:30PM Loading…
Dec-01-23 04:30PM
Nov-16-23 09:40AM
Nov-14-23 09:15PM
04:05PM
Nov-06-23 08:50AM
Oct-31-23 09:40AM
Oct-19-23 08:50AM
Oct-16-23 07:00AM
Oct-06-23 01:01PM
Oct-05-23 04:05PM
08:50AM Loading…
Oct-03-23 08:50AM
Oct-02-23 11:56PM
04:36PM
Sep-29-23 10:00AM
10:00AM
Sep-28-23 07:53AM
Sep-27-23 04:09PM
12:25PM
12:00PM
Sep-14-23 07:00AM
Sep-05-23 07:00AM
Aug-09-23 06:01AM
Jul-31-23 09:31AM
06:59AM
Jul-27-23 12:50PM
07:00AM Loading…
07:00AM
Jun-27-23 05:31AM
Jun-02-23 09:11AM
Jun-01-23 04:08PM
01:01PM
11:29AM
May-31-23 07:00AM
May-25-23 05:00PM
May-24-23 01:30PM
May-12-23 04:30PM
May-05-23 10:43AM
Apr-17-23 07:00AM
Mar-30-23 09:40AM
Mar-25-23 09:22AM
Mar-23-23 04:05PM
11:09AM
Mar-22-23 07:30AM
Mar-14-23 07:30AM
Mar-13-23 11:39AM
Feb-23-23 08:36AM
Feb-21-23 07:30AM
Feb-10-23 02:55PM
Feb-02-23 12:52PM
Jan-06-23 07:58AM
07:30AM
Jan-05-23 09:40AM
Dec-23-22 06:21AM
Nov-29-22 09:35AM
Nov-28-22 09:55AM
Nov-21-22 09:33AM
Nov-09-22 08:35AM
07:00AM
Nov-08-22 11:52AM
Nov-06-22 11:48AM
07:00AM
Nov-01-22 10:01AM
Oct-25-22 08:21PM
04:30PM
Oct-20-22 10:30PM
Oct-18-22 04:12PM
Oct-07-22 03:24AM
Oct-06-22 10:54AM
Oct-05-22 04:45PM
Oct-04-22 12:29PM
07:30AM
Oct-03-22 01:01PM
Sep-30-22 04:09PM
01:04PM
Sep-29-22 04:09PM
12:24PM
08:39AM
08:00AM
Sep-23-22 09:36AM
Sep-18-22 07:42PM
Sep-07-22 11:30AM
Aug-31-22 03:25PM
07:00AM
Aug-30-22 06:20AM
Aug-09-22 04:46PM
Aug-08-22 12:39PM
Aug-05-22 08:15AM
07:00AM
Aug-04-22 08:45AM
Aug-03-22 08:18PM
07:02AM
Jul-28-22 07:30AM
Jul-18-22 11:20AM
Jul-08-22 11:09AM
Jul-07-22 07:30AM
Jul-06-22 01:00PM
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Antonijevic IrinaDirectorDec 29Option Exercise0.0011,000013,535Dec 29 06:25 PM
Antonijevic IrinaDirectorDec 29Sale41.7911,000459,6622,535Dec 29 06:25 PM
CHILDS JOHN WDirectorOct 05Buy22.00454,5459,999,9903,998,952Oct 10 07:07 PM
Coric VladChief Executive OfficerOct 05Buy22.00340,9087,499,976833,120Oct 10 07:17 AM
Coric VladChief Executive OfficerOct 05Buy22.00113,6372,500,0141,657,031Oct 10 07:17 AM
Buten MatthewChief Financial OfficerOct 05Buy22.0022,727499,994189,380Oct 06 07:38 AM
Bailey GregoryDirectorOct 04Buy22.5717,817402,0941,525,788Oct 06 07:37 AM
CHILDS JOHN WDirectorAug 30Buy18.4450,000922,1801,975,118Aug 31 08:56 AM
CHILDS JOHN WDirectorAug 04Buy19.78100,0001,978,4301,925,118Aug 07 07:29 AM